Jump to navigation

South Africa

Experts and activists demand more generous vaccine waivers

Over a year after India and South Africa called for emergency measures, WTO members have proposed a plan to waive patents on COVID-19 vaccines

Pressure is building on President Cyril Ramaphosa to reject a compromise proposal offered by the United States and the European Union for a temporary waiver of intellectual property (IP) on Covid-19 vaccines (AC Vol 63 No 7, Vaccine patent negotiators agree compromise formula).

Over 300 civic activists, trades unions, academics, and experts from across the world, including economics laureate Joseph Stiglitz wrote to India's Prime Minister Narendra Modi and Ramaphosa describing the leaked text on IP waivers 'inadequate' and 'a step backwards from an already untenable status quo.'

It is almost 18 months since India and South Africa asked the World Trade Organization to waive IP rights for medicines in the hope of aiding the 'prevention, containment and treatment of Covid-19'.

South African and Indian officials joined the talks that led to the compromise text prepared by the US and EU, but Ramaphosa and his ministers are yet to comment on its contents.

The leaked text proposes that the waiver would cover IP rights only on vaccines but not on treatments for Covid-19. It also states that, within six months of a final agreement, WTO members must decide on whether to extend it to include Covid-19 diagnostics and therapeutics as well. For the moment, there is no timetable for a full WTO meeting to approve or reject the plan. It would require consensus support.

It also suggested that the agreement would be restricted to five years. The waiver would apply to those WTO members that exported less than 10% of the world's vaccine doses in 2021; that provision would mean the EU, China, and the US could not benefit from the waiver.

The proposal, despite its modesty, is opposed by the pharmaceutical conglomerates. The European Federation of Pharmaceutical Industries and Associations (EFPIA) called 'on governments across Europe and around the world to urgently rethink discussions on a Covid vaccine waiver and instead focus on the real barriers to global vaccine equity'.



Related Articles

DISPATCHES

Vaccine patent negotiators agree compromise formula

World Trade Organization chief Okonjo-Iweala applauds progress but warns of struggle to convince all members states to back it

The lead team of negotiators has agreed a compromise on patents waiver over three to five years for Covid-19 vaccines which will require ratification by all WTO members....

READ FOR FREE

Vote-getters and loyalists predominate

The President's reshuffle prioritises next year's elections instead of addressing the economy, infrastructure and electricity emergency

After serial delays and great expectations, President Cyril Ramaphosa brought in 10 new ministers for his reshuffle on 6 March with a wary eye on next year's general...


Politics and Pistorius in the dock

Jobs and corruption dominate the ANC’s ‘catalyst' election while people take a break from the trial of the century

Faction fighting, heated arguments over jobs and corruption – South Africa is back to politics as usual after the adjournment of the murder trial of Olympic athlete Oscar...


Scrambling for Africa

Business hopes that President Mbeki's pan-African vision can produce some profits too

As Pretoria flexes its diplomatic muscles in Africa, championing the New Partnership for Africa's Development and sending peacekeeping troops to Burundi and Congo-Kinshasa, its companies are following the...


Busting Billy

The South African police investigation into Zimbabwean entrepreneur Billy Rautenbach risks escalating into a diplomatic clash between Pretoria and Harare. Rautenbach is a close associate of Zimbabwe's Justice...